Chromosomal translocation products engender new intracellular therapeutic technologies

Nature Medicine

Volumn 9, Issue 4, 2003, Pages 383-386

  Rabbitts, Terence H ^a   Stocks, Martin R ^a  

^a MRC LABORATORY OF MOLECULAR BIOLOGY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

APTAMER; COMPLEMENTARY RNA; ENZYME INHIBITOR; HYBRID PROTEIN; IMATINIB; MESSENGER RNA; POLYAMIDE; REAGENT; RIBOZYME; ZINC;

ADOPTIVE IMMUNOTHERAPY; BIOLOGICAL MODEL; CANCER CELL; CHROMOSOME ANALYSIS; CHROMOSOME TRANSLOCATION; EPITHELIUM TUMOR; GENE FUSION; GENE TARGETING; GENE TRANSLOCATION; GENETIC TRANSCRIPTION; LEUKEMIA; LYMPHOMA; MOLECULAR BIOLOGY; NONHUMAN; PRIORITY JOURNAL; PROTEIN STRUCTURE; PROTEIN SYNTHESIS; REVIEW; SARCOMA; STRUCTURE ANALYSIS; ZINC FINGER MOTIF;

ANIMALS; ARTIFICIAL GENE FUSION; DISEASE MODELS, ANIMAL; DRUG DELIVERY SYSTEMS; HUMANS; MICE; NEOPLASMS; TRANSLOCATION, GENETIC;

EID: 0037393557     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/nm0403-383     Document Type: Review

References (23)

1. Rabbitts, T.H. Chromosomal translocations in human cancer. Nature 372, 143-149 (1994).
2. 2 zinc finger proteins. Ann. Rev. Biochem. 70, 313-340 (2001).
3. Gottesfeld, J.M., Neely, L., Trauger, J.W., Baird, E.E. & Dervan, P.B. Regulation of gene expression by small molecules. Nature 387, 202-205 (1997).
4. Stocks, M.R. & Rabbitts, T.H. Masked antisense: a molecular configuration for discriminating similar RNA targets. EMBO Reports 11, 59-64 (2000).
5. Kuwabara, T. et al. A novel allosterically trans-activated ribozyme, the maxizyme, with exceptional specificity in vitro and in vivo. Mol. Cell 2, 617-627 (1998).
6. Ullu, E., Djikeng, A., Shi, H. & Tschudi, C. RNA interference: advances and questions. Philos. Trans. R. Soc. Lond. B Biol. Sci. 357, 65-70 (2002).
7. Pinilla-Ibarz, J., Cathcart, K. & Scheinberg, D.A. CML vaccines as a paradigm of the specific immunotherapy of cancer. Blood Rev. 14, 111-120 (2000).
8. Druker, B. Signal transduction inhibition: results from phase I clinical trials in chronic myeloid leukemia. Semin. Hematol. 38, 9-14 (2001).
9. Cattaneo, A. & Biocca, S. The selection of Intracellular antibodies. Trends Biotech. 17, 115-121 (1999).
10. Tanaka, T. & Rabbitts, T.H. Intrabodies based on intracellular capture frameworks that bind the RAS protein with high affinity and impair oncogenic transformation. EMBO]. (in the press).
11. Geyer, C.R. & Brent, R. Selection of genetic agents from random peptide aptamer expression libraries. Methods Enzymol. 328, 171-208 (2000).
12. He, L.Z. et al. Distinct interactions of PML-RARα and PLZF-RARα with co-repressors determine differential responses to RA in APL. Nat. Genet. 18, 126-135 (1998).
13. Adams, J.M. & Cory, S. Transgenic models of tumor development. Science 254, 1161-1167 (1991).
14. Ayton, P.M. & Cleary, M.L. Molecular mechanisms of leukemogenesis mediated by MLL fusion proteins. Oncogene Rev. 20, 5695-5707 (2001).
15. Yergeau, D.A. et al. Embryonic lethality and impairment of haematopoiesis in mice heterozygous for an AML1-ETO fusion gene. Nat. Genet. 15, 303-306 (1997).
16. Buchholz, F., Refaeli, Y., Trumpp, A. & Bishop, J.M. Inducible chromosomal translocation of AML1 and ETO genes through Cre/loxP-mediated recombination in the mouse. EMBO Reports 1, 133-139 (2000).
17. Collins, E.C., Pannell, R., Simpson, E.M., Forster, A. & Rabbitts, T.H. Inter-chromosomal recombination of Mll and Af9 genes mediated by cre-loxP in mouse development. EMBO Reports 1, 127-132 (2000).
18. Higuchi, M. et al. Expression of a conditional AML1-ETO oncogene bypasses embryonic lethality and establishes a murine model of human t(8;21) acute myeloid leukemia. Cancer Cell 1, 63-74 (2002).
19. Tse, E. & Rabbitts, T.H. Intracellular antibody-caspase mediated cell killing: a novel approach for application in cancer therapy. Proc. Natl. Acad. Sci. USA 97, 12266-12271 (2000).
20. Elliott, G. & O'Hare, P. Intercellurar trafficking and protein delivery by a herpesvirus structural protein. Cell 88, 223-233 (1997).
21. Derossi, D., Chassaing, G. & Prochiantz, A. Trojan peptides: The penetratin system for intracellular delivery. Trends Cell Biol. 8, 84-87 (1998).
22. Becker-Hapak, M., McAllister, S.S. & Dowdy, S.F. TAT-mediated protein transduction into mammalian cells. Methods 24, 247-256 (2001).
23. Darnell, J.E. Transcription factors as targets for cancer therapy. Nat. Rev. Cancer 2, 740-749 (2002).